Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion type Assertion NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_head.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion description "[In this study we sought to determine whether EMMPRIN contributes to the malignant phenotype of breast cancer by inhibiting anoikis, a form of apoptosis induced by loss or alteration of cell-cell or cell-matrix anchorage, and to explore the signaling pathways involved.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_provenance.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion evidence source_evidence_literature NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_provenance.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion SIO_000772 16443928 NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_provenance.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion wasDerivedFrom befree-20140225 NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_provenance.
- NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_assertion wasGeneratedBy ECO_0000203 NP427714.RA9hMXdy9NYK1YasUW-Vd6Wfhn_nnE4RztT315MEdMN5E130_provenance.